| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |